Relay Therapeutics stock hits 52-week high at $7.01
PositiveFinancial Markets

Relay Therapeutics has reached a significant milestone as its stock hit a 52-week high of $7.01. This achievement reflects growing investor confidence in the company's innovative approach to drug discovery and development. As the biotech sector continues to evolve, Relay's advancements could lead to promising treatments, making this news particularly relevant for investors and stakeholders in the healthcare industry.
— Curated by the World Pulse Now AI Editorial System